Previous issue | Volume 92 | ESPE2019

58th Annual ESPE meeting

Vienna, Austria
19 Sep 2019 - 21 Sep 2019

Card image cap
The theme of this year’s meeting is Variety and Variation in Paediatric Endocrinology. Join us in Vienna to explore the diversity we encounter in our discipline and the care that we have to exercise when using the term “normality”. Whilst gaining an update on the latest treatments, clinical best practice and cutting edge research in the field of paediatric endocrinology.

Free Communications

Bone, Growth Plate and Mineral Metabolism Session 2

Bone Tissue Characterization of a Mouse Model of Atypical Type VI Osteogenesis Imperfecta Reveals Hypermineralization of the Bone Matrix, Elevated Osteocyte Lacunardensity and Altered Vascularity
1Ludwig Boltzmann Institute of Osteology at Hanusch Hospital of WGKK and AUVA Trauma Centre, Meidling,1st Med. Department Hanusch Hospital, Vienna, Austria. 2Section on Heritable Disorders of Bone and Extracellular Matrix, NICHD, NIH, Bethesda, USA
hrp0092fc6.1
Zone Wise Cell Separation Methods Comparison, Based on Relative Expression of Specific Growth Plate Markers in a Pig Model
1Clinic for pediatric and adolescent medicine, Medical University of Vienna, Vienna, Austria. 2Histology & Embryology, Department of Pathobiology, University of Veterinary Medicine Vienna, Vienna, Austria. 3Center for Medical Statistics, Informatics and Intelligent Systems, Medical University of Vienna, Vienna, Austria
hrp0092fc6.2
Decreased Trabecular Bone Mineral Density and Muscle Area at the Forearm Despite Improvement in Glycaemic Control Over 3 Years After Simultaneous Pancreas Kidney Transplantation
1Department of Pediatrics, Charles University and Motol University Hospital, Prague, Czech Republic. 2Diabetes Centre, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
hrp0092fc6.3
Metabolically Unhealthy Obese Children and Adolescents Have Higher Bone Mineral Density Than Normal Weighted Controls but Lower than Metabolically Healthy Obeses: No Effect of FGF21 Levels
1Ankara University School of Medicine, Department of Pediatrics, Ankara, Turkey. 2Ankara University School of Medicine, Department of Pediatric Endocrinology, Ankara, Turkey. 3Ankara University School of Medicine, Department of Clinical Biochemistry, Ankara, Turkey. 4Ankara University School of Medicine, Department of Nuclear Medicine, Ankara, Turkey
hrp0092fc6.4
No Change in Bone Density During 6 Months Off GH in Adolescents with Severe GHD at Near-Adult Height
1University Children's Hospital, Pediatric Endocrinology, Tübingen, Germany. 2The Warren Alpert Medical School of Brown University, Providence, USA
hrp0092fc6.5
Craniosynostosis in Inactivating PTH/PTHrP Signaling Disorder 2: A Non-Classical Feature to Consider
1Pediatric Endocrinology. Pediatrics. Hospital Universitario Central de Asturias, Oviedo, Spain. 2University of Oviedo, Oviedo, Spain. 3Spanish Consortium for Research on Epidemiology and Public Health (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain. 4APHP, Reference Center for Rare Disorders of the Calcium and Phosphate Metabolism, filière OSCAR and Plateforme d´éxpertise Maladies Rares Paris-Sud, Le Kremlin Bicètre, France. 5APHP, Department of Endocrinology and Diabetology, Bicêtre Paris Sud hospital, Le Kremlin Bicètre, France. 6APHP, Reference Center for Rare Disorders of the Calcium and Phosphate Metabolism, filière OSCAR and Plateforme déxpertise Maladies Rares Paris-Sud, Le Kremlin Bicètre, France. 7INSERM U1169, Hôpital Bicêtre, Le Kremlin Bicètre, France. 8Fondazione IRCCS Ca´Granda Ospedale Maggiore Policlinico, Endocrinology and Diabetology Unit, Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy. 9Molecular (Epi)Genetics Laboratory, bioAraba National Health Institute, OSI Araba University Hospital, Vitoria-Gasteiz, Spain
hrp0092fc6.6